Skip to main content
. 2018 May 25;144(8):1423–1434. doi: 10.1007/s00432-018-2679-4

Table 1.

Clinical–demographic characteristics and nutritional status of studied patients

Factor Study group (n = 62)
Gender
 Male 51 (82.2%)
 Female 11 (17.8%)
Age, median (range) 63 (42–87)
 ≥ 63 32 (48.4%
 < 63 30 (51.6%)
Histopathological diagnosis
 Squamous-cell carcinoma 57 (91.9%)
 Other 5 (8.1%)
Tumor location
 Upper throat 17 (27.4%)
 Lower throat 45 (72.6%)
 Larynx 34 (54.8%)
 Others 28 (45.2%)
T stage
 T1 2 (3.2%)
 T2 9 (14.5%)
 T3 15 (24.2%)
 T4 36 (58.1%)
N stage
 Nx 2 (3.2%)
 N0 18 (29%)
 N1 6 (9.7%)
 N2 32(51.6%)
 N3 4 (6.5%)
M stage
 Mx 3(75%)
 M1 1 (25%)
Disease stage
 I 2 (3.2%)
 III 12 (19.4%)
 IVA 40 (64.5%)
 IVB 3 (4.8%)
 IVC 5 (8.1%)
Performance status (PS)
 ≤ 1 55 (88.7%)
 > 1 7 (11.3%)
Type of treatment
 Surgery + RTH 28 (45.2%)
 Surgery + chemoradiation 17 (27.4%)
 RTH alone 7 (11.3%)
 Induction CHTH + RTH 3 (4.8%)
 Concurrent chemoradiation 7 (11.3%)
Alcohol consumption
 Yes 28 (45.2%)
 No 34 (54.8%)
Smoking status
 Smoker 52 (83.9%)
 Non-smoker 10 (16.1%)
 Current smoker 45 (86.5%)
 Former smoker 7 (13.5%)
Nutritional status
 Parenteral nutrition
  Yes 13 (21%)
  No 49 (79%)
 Weight (kg)
  Mean ± SD 65.63 ± 11.93
 BMI
  Mean ± SD 23.13 ± 4.44
  > 18.5 52 (83.9%)
  < 18.5 10 (16.1%)
 SGA
  A 9 (14.5%)
  B 29 (46.8%)
  C 24 (38.7%)
 NRS
  2 42 (67.8%)
  3 18 (29%)
  4 2 (3.2)
 Total protein (g/L)
  Median ± SD 6.72 ± 0.52
 Albumin (g/L)
  Median ± SD 3.33 ± 0.24
 Prealbumin(g/dL)
  Median ± SD 0.20 ± 0.08
 Transferrin(g/L)
  Median ± SD 2.50 ± 0.60